MRI Prostate (Multiparametric MRI) is a highly specialised, radiation-free scan used to assess the prostate gland in detail. It is the most accurate non‑invasive test for detecting clinically significant prostate cancer, monitoring known lesions, and evaluating PSA abnormalities. All Medicare‑eligible MRI prostate studies are fully bulk‑billed at Advicon Imaging.

On this page
MRI Prostate uses multiparametric imaging—combining anatomical sequences, diffusion imaging, and dynamic contrast enhancement—to detect, localise, and grade suspicious areas within the prostate.
It provides clearer information than ultrasound and is now widely used to guide diagnosis and management.
MRI Prostate is commonly used for:
Multiparametric MRI evaluates:
All prostate MRI scans are reported using the **PI‑RADS v2.1** scoring system to standardise cancer risk assessment.
Advantages:
At Advicon Imaging, prostate MRI is performed using advanced MRI technology and interpreted by experienced radiologists.
Advicon Imaging – High‑resolution multiparametric prostate MRI with full Medicare bulk‑billing for eligible studies.
It helps evaluate elevated PSA levels, abnormal exam findings, or monitor known prostate lesions.
Yes. MRI uses magnetic fields instead of radiation.
You must inform us if you have metal implants or pacemakers.
Yes:
Yes. Most prostate MRI scans use gadolinium contrast as part of the multiparametric protocol.
Typically 25-40 minutes.
No. MRI is painless, though lying still is required.
PI‑RADS is an international scoring system that classifies the likelihood of clinically significant prostate cancer (1 to 5).
MRI significantly reduces unnecessary biopsies, but suspicious lesions (PI‑RADS 4–5) may still need a targeted biopsy.
Reports are usually available within 24–48 hours.
Yes. All Medicare‑eligible MRI prostate studies are fully bulk‑billed at Advicon Imaging.